Literature DB >> 23562731

The leukocyte chemotactic receptor FPR2, but not the closely related FPR1, is sensitive to cell-penetrating pepducins with amino acid sequences descending from the third intracellular receptor loop.

Huamei Forsman1, Johan Bylund, Tudor I Oprea, Anna Karlsson, Francois Boulay, Marie-Josephe Rabiet, Claes Dahlgren.   

Abstract

Lipidated peptides (pepducins) can activate certain G-protein coupled receptors (GPCRs) through a unique allosteric modulation mechanism involving cytosolic receptor domains. Pepducins with the amino acid sequence of the third intracellular loop of the neutrophil formyl peptide receptors (FPRs) as a common denominator were N-terminally conjugated with palmitic acid. F2Pal16, containing the 16 amino acids present in the third intracellular loop of FPR2, induced superoxide production in human neutrophils and the activity was sensitive to FPR2 antagonists. Cells over-expressing FPR2 were similarly responsive and responded with a transient increase in cytosolic calcium. No such effects were observed with the corresponding FPR1 pepducin. The peptide alone, lacking palmitic acid, did not activate neutrophils. A ten amino acid long pepducin F2Pal10, that was a more potent neutrophil activator than F2Pal16, was used for amino acid substitution studies. The sequences of FPR1 and FPR2 in the third intracellular loop differ by only two amino acids, and a pepducin with the FPR2-specific K231 replaced by the FPR1-specific Q231 lost all activity. The active F2Pal10 pepducin also triggered a response in cells expressing a mutated FPR2 with the third intracellular loop identical to that of FPR1. The data presented suggest that the same signaling pathways are activated when the signaling cascade is initiated by a classical receptor agonist (outside-in signaling) and when signaling starts on the cytosolic side of the membrane by a pepducin (inside-in signaling). A fundamental difference is also disclosed between the two neutrophil FPRs regarding their sensitivities to third intracellular loop pepducins.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23562731     DOI: 10.1016/j.bbamcr.2013.03.026

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Effect of a novel peptide, WKYMVm- and sirolimus-coated stent on re-endothelialization and anti-restenosis.

Authors:  Eun-Jae Jang; In-Ho Bae; Dae Sung Park; So-Youn Lee; Kyung Seob Lim; Jun-Kyu Park; Jae-Won Shim; Doo Sun Sim; Myung Ho Jeong
Journal:  J Mater Sci Mater Med       Date:  2015-10-05       Impact factor: 3.896

2.  Antibacterial activity of pepducins, allosterical modulators of formyl peptide receptor signaling.

Authors:  Malene Winther; Michael Gabl; Tudor I Oprea; Bodil Jönsson; Francois Boulay; Johan Bylund; Claes Dahlgren; Huamei Forsman
Journal:  Antimicrob Agents Chemother       Date:  2014-03-03       Impact factor: 5.191

Review 3.  [Novel achievements in development and application of GPCR-peptides].

Authors:  A O Shpakov; K V Derkach
Journal:  Zh Evol Biokhim Fiziol       Date:  2015 Jan-Feb

Review 4.  Neutrophil Signaling That Challenges Dogmata of G Protein-Coupled Receptor Regulated Functions.

Authors:  Claes Dahlgren; André Holdfeldt; Simon Lind; Jonas Mårtensson; Michael Gabl; Lena Björkman; Martina Sundqvist; Huamei Forsman
Journal:  ACS Pharmacol Transl Sci       Date:  2020-03-11

5.  Pepducins and Other Lipidated Peptides as Mechanistic Probes and Therapeutics.

Authors:  Ping Zhang; Lidija Covic; Athan Kuliopulos
Journal:  Methods Mol Biol       Date:  2015

Review 6.  Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives.

Authors:  Igor A Schepetkin; Andrei I Khlebnikov; Liliya N Kirpotina; Mark T Quinn
Journal:  Int Immunopharmacol       Date:  2015-09-15       Impact factor: 4.932

Review 7.  Targeting of G-protein coupled receptors in sepsis.

Authors:  Abdul Rehman; Noor Ul-Ain Baloch; John P Morrow; Pál Pacher; György Haskó
Journal:  Pharmacol Ther       Date:  2020-03-19       Impact factor: 12.310

8.  The Lipidated Peptidomimetic Lau-((S)-Aoc)-(Lys-βNphe)6-NH2 Is a Novel Formyl Peptide Receptor 2 Agonist That Activates Both Human and Mouse Neutrophil NADPH Oxidase.

Authors:  André Holdfeldt; Sarah Line Skovbakke; Malene Winther; Michael Gabl; Christina Nielsen; Iris Perez-Gassol; Camilla Josephine Larsen; Ji Ming Wang; Anna Karlsson; Claes Dahlgren; Huamei Forsman; Henrik Franzyk
Journal:  J Biol Chem       Date:  2016-07-15       Impact factor: 5.157

9.  Formyl peptide derived lipopeptides disclose differences between the receptors in mouse and men and call the pepducin concept in question.

Authors:  Malene Winther; André Holdfeldt; Martina Sundqvist; Zahra Rajabkhani; Michael Gabl; Johan Bylund; Claes Dahlgren; Huamei Forsman
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

10.  A pepducin derived from the third intracellular loop of FPR2 is a partial agonist for direct activation of this receptor in neutrophils but a full agonist for cross-talk triggered reactivation of FPR2.

Authors:  Michael Gabl; Malene Winther; Sarah Line Skovbakke; Johan Bylund; Claes Dahlgren; Huamei Forsman
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.